Enanta Pharmaceuticals Inc.
ENTA | NASDAQ
$12.42
+$0.31 (+2.56%)
Sep 22, 2026, 2:41 PM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 33.42M | 34.93M | 37.44M | 32.3M | 44.81M | 60.21M | 84.35M | 37.23M | 35.78M | 63.54M | 39.93M | 85.39M | 95.18M | 73.18M | 42.22M | 43.99M | 28.37M | 40.99M | 99.07M | 57.21M | 4.6M | 77.13M | 55.1M |
Short-Term Investments | 156.09M | 128.85M | 148.41M | 156.57M | 159.3M | 133.16M | 132.34M | 210.95M | 194.31M | 236.77M | 297.22M | 284.52M | 291.41M | 136.91M | 172.25M | 205.24M | 224.92M | 239.34M | 159.98M | 186.8M | 252.22M | 298.82M | 331.1M |
Long-Term Investments | n/a | 66.6M | 56.06M | 3.36M | 3.36M | n/a | n/a | n/a | 42.51M | 3.97M | 3.97M | n/a | 5.92M | 15.04M | 30.91M | 33.25M | 43.4M | 42.83M | 89.28M | 109.02M | 116.31M | 25.1M | 19.07M |
Other Long-Term Assets | 25.46M | 144K | 3.45M | 92K | 94K | 3.46M | 3.45M | 3.45M | 3.47M | 187K | 765K | 4.77M | 4.8M | 4.66M | 701K | 696K | 703K | 92K | 92K | 92K | 92K | 92K | 92K |
Receivables | 6.53M | 7.83M | 8.49M | 6.88M | 8.36M | 40.63M | 40.16M | 38.65M | 40.63M | 39.79M | 39.91M | 39.62M | 18.89M | 17.8M | 51.29M | 49.04M | 48.21M | 47.46M | 56.4M | 60.83M | 52.19M | 20.13M | 31.74M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 7.58M | 6.81M | 4.34M | 8.59M | 10.24M | 8.86M | 11.29M | 13.02M | 15.87M | 10.93M | 13.25M | 13.26M | 25.92M | 28.77M | 17.95M | 13.45M | 11.54M | 14.08M | 11.51M | 14.19M | 12.14M | 32.14M | 28M |
Total Current Assets | 203.62M | 178.41M | 198.68M | 204.34M | 222.71M | 242.86M | 268.15M | 299.85M | 286.58M | 351.03M | 390.3M | 422.79M | 448.47M | 271.14M | 283.7M | 311.71M | 313.04M | 341.87M | 326.96M | 319.02M | 321.16M | 428.22M | 445.94M |
Property-Plant & Equipment | 67.79M | 69.55M | 71.31M | 72.94M | 74.87M | 76.68M | 77.04M | 73.35M | 66.26M | 58.37M | 33.46M | 34.71M | 35.98M | 35.6M | 32.22M | 29.75M | 28.08M | 22.03M | 24.27M | 10.65M | 12.53M | 14.01M | 15.56M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 93.25M | 136.29M | 130.82M | 76.4M | 78.32M | 80.13M | 80.5M | 76.8M | 112.24M | 62.53M | 38.2M | 39.48M | 46.7M | 55.31M | 63.83M | 68.88M | 72.18M | 64.95M | 113.64M | 121.84M | 129.28M | 39.55M | 35.07M |
Total Assets | 296.87M | 314.7M | 329.5M | 280.73M | 301.03M | 322.99M | 348.64M | 376.65M | 398.82M | 413.56M | 428.5M | 462.28M | 495.17M | 326.45M | 347.53M | 380.59M | 385.21M | 406.82M | 440.59M | 440.86M | 450.44M | 467.77M | 481.01M |
Account Payables | 3.29M | 4.36M | 1.89M | 1.95M | 3.55M | 4.76M | 4.73M | 8M | 10.68M | 6.73M | 9.33M | 4.1M | 7.93M | 11.76M | 4.35M | 6M | 1.25M | 5.99M | 7.84M | 9.54M | 5.9M | 5.7M | 6.31M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 3.91M | 35.22M | 31.98M | 30.71M | 27.76M | 30.68M | 32.74M | 34.46M | 32.3M | 33.67M | 41.48M | 35.08M | 36.69M | n/a | 3.49M | 2.89M | 2.6M | 3.01M | 3.47M | 4.2M | 5.03M | 5.18M | 5.2M |
Other Current Liabilities | 50.26M | 3.92M | n/a | n/a | 6.08M | n/a | n/a | n/a | 8.04M | 7.66M | 2.33M | n/a | n/a | -1 | 12.57M | 14.5M | 14.34M | 18.78M | 24.16M | 16.34M | 13.33M | 13.15M | 9.31M |
Total Current Liabilities | 54.17M | 46.44M | 44.73M | 48.56M | 44.55M | 45.95M | 49.05M | 57.54M | 58.23M | 54.61M | 62.41M | 62.79M | 68.19M | 32.17M | 23M | 29.83M | 23.04M | 30.74M | 37.89M | 36.17M | 28.62M | 26.62M | 23.04M |
Long-Term Debt | 51.75M | 98.62M | 104.13M | 112.44M | 121.29M | 126.73M | 131.09M | 136.13M | 143.31M | 149.2M | 153.04M | 160.85M | 166.4M | 1.42M | 1.42M | 1.42M | 1.51M | 1.51M | 1.51M | 1.51M | 1.48M | 1.48M | 1.48M |
Other Long-Term Liabilities | 89.89M | 278K | 269K | 260K | 252K | 243K | 235K | 231K | 227K | 224K | 649K | 663K | 426K | 408K | 414K | 454K | 441K | 876K | 856K | 558K | 846K | 994K | 974K |
Total Long-Term Liabilities | 141.64M | 151.67M | 158.18M | 167.46M | 177.2M | 183.51M | 187.78M | 190.3M | 191.68M | 192.84M | 174.21M | 182.75M | 189.16M | 24.9M | 23.7M | 29.43M | 24.16M | 17.5M | 18.32M | 5.26M | 3.96M | 5.12M | 5.97M |
Total Liabilities | 195.8M | 198.12M | 202.91M | 216.02M | 221.75M | 229.46M | 236.83M | 247.84M | 249.91M | 247.44M | 236.62M | 245.54M | 257.35M | 57.07M | 46.7M | 59.26M | 47.19M | 48.24M | 56.21M | 41.43M | 32.59M | 31.74M | 29.02M |
Total Debt | 55.66M | 186.62M | 193.18M | 201.06M | 207.1M | 216.14M | 221.29M | 226.06M | 226.17M | 229.86M | 220M | 222.44M | 230.8M | 29.42M | 26.77M | 26.69M | 26.31M | 19.63M | 20.93M | 6.84M | 8.15M | 9.3M | 10.2M |
Book Value | 101.07M | 116.59M | 126.59M | 64.72M | 79.28M | 93.54M | 111.82M | 128.81M | 148.92M | 166.11M | 191.88M | 216.74M | 237.82M | 269.38M | 300.84M | 321.33M | 338.02M | 358.58M | 384.38M | 399.43M | 417.85M | 436.03M | 452M |
Book Value Per Share | 3.47 | 4.01 | 4.40 | 3.03 | 3.72 | 4.38 | 5.26 | 6.08 | 7.03 | 7.85 | 9.10 | 10.29 | 11.30 | 12.81 | 14.45 | 15.60 | 16.32 | 17.45 | 18.85 | 19.75 | 20.68 | 21.62 | 22.50 |
Common Stock | 291K | 291K | 290K | 214K | 214K | 214K | 213K | 212K | 212K | 212K | 212K | 211K | 210K | 210K | 209K | 208K | 207K | 206K | 205K | 202K | 202K | 202K | 201K |
Retained Earnings | -449.46M | -429.96M | -416.87M | -404.93M | -386.23M | -367.97M | -345.33M | -323.04M | -294.22M | -271.56M | -240.4M | -207M | -178.89M | -139.82M | -102.17M | -73.18M | -46.83M | -15.13M | 18.46M | 48.58M | 73.18M | 97.2M | 119.24M |
Comprehensive Income | -927K | -734K | -329K | -339K | -402K | -224K | -29K | 302K | -653K | -667K | -534K | -1.17M | -1.5M | -1.81M | -2.68M | -3.72M | -3.62M | -3.04M | -1.01M | -382K | -264K | 55K | 405K |
Shareholders Equity | 101.07M | 116.59M | 126.59M | 64.72M | 79.28M | 93.54M | 111.82M | 128.81M | 148.92M | 166.11M | 191.88M | 216.74M | 237.82M | 269.38M | 300.84M | 321.33M | 338.02M | 358.58M | 384.38M | 399.43M | 417.85M | 436.03M | 452M |
Total Investments | 156.09M | 195.44M | 204.47M | 159.93M | 162.66M | 133.16M | 132.34M | 210.95M | 236.82M | 240.74M | 301.19M | 284.52M | 297.33M | 151.95M | 203.15M | 238.49M | 268.32M | 282.16M | 249.26M | 295.82M | 368.54M | 323.92M | 350.17M |
Add to Watchlist
Select watchlists to add or remove ENTA